Unaudited interim condensed consolidated statement of changes in shareholders' equity - EUR (€) |
Share capital |
Premiums related to share capital |
Net profit (loss) |
Translation reserves |
Reserves |
Total |
|---|---|---|---|---|---|---|
| Balance at the beginning at Dec. 31, 2023 | € 521,000 | € 201,862,000 | € (110,426,000) | € 596,000 | € (124,584,000) | € (32,032,000) |
| Balance at the beginning (in shares) at Dec. 31, 2023 | 52,115,807 | |||||
| Net loss for the period | (49,029,000) | (49,029,000) | ||||
| Other comprehensive income | (146,000) | |||||
| Remeasurement of defined benefit plans | 74,000 | 74,000 | ||||
| Currency translation differences | (220,000) | (220,000) | ||||
| Total comprehensive loss | (49,029,000) | (220,000) | 74,000 | (49,175,000) | ||
| Appropriation of net income (loss) | 110,426,000 | (110,426,000) | ||||
| Share-based payment compensation expenses | 2,238,000 | 2,238,000 | ||||
| BSA share warrants subscription premium | € 4,000 | (4,000) | (6,000) | (6,000) | ||
| Treasury shares | (138,000) | (138,000) | ||||
| Other | 41,000 | 41,000 | ||||
| Balance at the end (in shares) at Jun. 30, 2024 | 52,477,188 | |||||
| Balance at the end at Jun. 30, 2024 | € 525,000 | 201,859,000 | (49,029,000) | 375,000 | (232,789,000) | (79,060,000) |
| Balance at the beginning at Dec. 31, 2023 | € 521,000 | 201,862,000 | (110,426,000) | 596,000 | (124,584,000) | (32,032,000) |
| Balance at the beginning (in shares) at Dec. 31, 2023 | 52,115,807 | |||||
| Appropriation of net income (loss) | € 184,200,000 | |||||
| Balance at the end (in shares) at Dec. 31, 2024 | 95,662,391 | 95,662,391 | ||||
| Balance at the end at Dec. 31, 2024 | € 956,623.91 | 249,159,596.78 | (184,212,000) | 600,000 | (173,151,000) | € (106,647,000) |
| BSA share warrants subscription premium (in shares) | 361,381,000 | |||||
| Net loss for the period | (175,882,000) | (175,882,000) | ||||
| Other comprehensive income | (167,000) | |||||
| Remeasurement of defined benefit plans | 93,000 | 93,000 | ||||
| Currency translation differences | (260,000) | (260,000) | ||||
| Total comprehensive loss | (175,882,000) | (260,000) | 93,000 | (176,049,000) | ||
| Appropriation of net income (loss) | 184,212,000 | (184,212,000) | ||||
| Issue of ordinary shares | € 435,000 | 135,115,000 | 135,550,000 | |||
| Issue of ordinary shares (in shares) | 43,488,883 | |||||
| Transaction costs | (7,519,000) | (7,519,000) | ||||
| Issue of prefunded warrants | 138,130,000 | 138,130,000 | ||||
| Share-based payment compensation expenses | 8,009,000 | 8,009,000 | ||||
| Treasury shares | 85,000 | 85,000 | ||||
| Other | (467,000) | € (467,000) | ||||
| Balance at the end (in shares) at Jun. 30, 2025 | 139,151,274 | 139,151,274 | ||||
| Balance at the end at Jun. 30, 2025 | € 1,391,512.74 | € 376,754,830.25 | € (175,882,000) | € 340,000 | € (211,513,000) | € (8,909,000) |